UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): September 10, 2014

 

 

GI DYNAMICS, INC.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   000-55195   84-1621425

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

25 Hartwell Avenue

Lexington, MA 02421

(Address of principal executive offices and zip code)

Registrant’s telephone number, including area code: (781) 357-3300

(Former name or former address, if changed since last report.)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

(d) On September 10, 2014, the Company issued a press release announcing the appointment of Daniel Jeffrey Moore to the Company’s Board of Directors (the “Board”) as a Class III director to serve until the 2017 Annual Meeting of Stockholders and thereafter until his successor is duly elected and qualified, effective as of September 10, 2014 (the “Effective Date”). A copy of the press release announcing Mr. Moore’s appointment is attached hereto as Exhibit 99.1.

Mr. Moore will be compensated for his service on the Company’s Board under the Company’s Non-Employee Director Compensation Policy (the “Policy”), a copy of which is filed as Exhibit 10.1 to this Current Report on Form 8-K and is incorporated herein by reference. Pursuant to the Policy and in connection with his appointment to the Company’s Board, on September 10, 2014 (the “Grant Date”) the Board granted Mr. Moore a non-qualified stock option (the “Option”) to purchase 80,000 shares of the Company’s common stock, par value $0.01 per share, (the “Common Stock”) at an exercise price equal to the fair market value per share, which Option shall vest over three years from the Grant Date in (i) one installment of 33% of the shares on the first anniversary of the Grant Date and (ii) twenty-four substantially equal monthly installments thereafter, subject to Mr. Moore’s continued service on the Board. In the event of a change of control of the Company (as defined in the Option grant paperwork), the Option shall become vested in full.

The Company shall also pay to Mr. Moore an annual retainer of $50,000 plus any relevant committee fees, if Mr. Moore becomes a member of one or more of the Company’s committees.

There are no related party transactions involving the Company that are required to be disclosed pursuant to Item 404(a) of Regulation S-K related to Mr. Moore.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

See Exhibit Index attached hereto, which is incorporated by reference herein.


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

      GI DYNAMICS, INC.
Dated: September 12, 2014      

/s/ Robert Crane

      Robert Crane
      Chief Financial Officer


EXHIBIT INDEX

 

Exhibit
No.

  

Description

10.1    Non-Employee Director Compensation Policy
99.1    Press Release of GI Dynamics, Inc. dated September 10, 2014

Exhibit 10.1

GI DYNAMICS, INC.

NON-EMPLOYEE DIRECTOR COMPENSATION POLICY

The Compensation Committee of the Board of Directors of GI Dynamics, Inc. (the “ Company ”) has approved the following Non-Employee Director Compensation Policy (this “ Policy ”) which establishes compensation to be paid to non-employee directors of the Company, effective as of August 1, 2011 (the “ Effective Time ”), to provide an inducement to obtain and retain the services of qualified persons to serve as members of the Company’s Board of Directors.

Applicable Persons

This Policy shall apply to each director of the Company who is not an employee of, or consultant to, the Company or any Affiliate (each, an “ Outside Director ”). “Affiliate” shall mean a corporation which is a direct or indirect parent or subsidiary of the Company, as determined pursuant to Section 424 of the Internal Revenue Code of 1986, as amended.

Stock Option Grants

All stock option amounts set forth herein shall be subject to automatic adjustment in the event of any stock split or other recapitalization affecting the Company’s common stock.

Initial Stock Option Grants for Existing Directors

Upon the adoption by the Board of Directors of the Company’s 2011 Employee, Director and Consultant Equity Incentive Plan (the “ Stock Plan ”), each Outside Director shall be granted a non-qualified stock option (the “ Existing Director Initial Option Grant ”) to purchase 130,000 shares of the Company’s common stock under the Stock Plan. Each such option shall vest over five years from the date of the grant in (i) one installment of 20% of the shares on the first anniversary of the date of the grant and (ii) forty-eight substantially equal monthly installments thereafter, each subject to the Outside Director’s continued service on the Board of Directors.

Initial Stock Option Grant For Newly Appointed or Elected Directors

Each Outside Director whose service on the Board of Directors commences following the date of adoption of the Stock Plan and prior to the annual meeting of stockholders in 2012 shall, subject to shareholder approval being obtained under the ASX Listing Rules, be granted a non-qualified stock option to purchase 130,000 shares of the Company’s common stock under the Stock Plan on the date of his or her initial appointment or election to the Board of Directors. Each such option shall vest over five years from the date of the grant in (i) one installment of 20% of the shares on the first anniversary of the date of the grant and (ii) forty-eight substantially equal monthly installments thereafter, each subject to the Outside Director’s continued service on the Board of Directors.


Each Outside Director whose service on the Board of Directors commences at or following the annual meeting of stockholders in 2012 and prior to the annual meeting of stockholders in 2013 shall, subject to shareholder approval being obtained under the ASX Listing Rules, be granted a non-qualified stock option to purchase 105,000 shares of the Company’s common stock under the Stock Plan on the date of his or her initial appointment or election to the Board of Directors. Each such option shall vest over four years from the date of the grant in (i) one installment of 25% of the shares on the first anniversary of the date of the grant and (ii) thirty-six substantially equal monthly installments thereafter, each subject to the Outside Director’s continued service on the Board of Directors.

Each Outside Director whose service on the Board of Directors commences at or following the annual meeting of stockholders in 2013 shall, subject to shareholder approval being obtained under the ASX Listing Rules, be granted a non-qualified stock option to purchase 80,000 shares of the Company’s common stock under the Stock Plan on the date of his or her initial appointment or election to the Board of Directors. Each such option shall vest over three years from the date of the grant in (i) one installment of 33% of the shares on the first anniversary of the date of the grant and (ii) twenty-four substantially equal monthly installments thereafter, each subject to the Outside Director’s continued service on the Board of Directors.

Annual Equity Incentive Grants

Commencing in 2014, each Outside Director shall, subject to any required shareholder approval being obtained under the ASX Listing Rules, be granted (i) a non-qualified stock option (the “Annual Option Grant”) to purchase 10,000 shares of the Company’s common stock under the Stock Plan, and (ii) a restricted stock unit (the “Annual RSU Grant”) with respect to 10,000 shares of the Company’s common stock under the Stock Plan, each year on or about the annual meeting of the Board of Directors following the Company’s annual meeting of stockholders. Each Annual Option Grant and Annual RSU Grant shall vest over three years from the date of the grant in thirty-six substantially equal monthly installments, each subject to the Outside Director’s continued service on the Board of Directors.

Terms for All Option Grants

Unless otherwise specified by the Board of Directors or the Compensation Committee at the time of grant, all options granted under this Policy shall (i) have an exercise price equal to the fair market value of the Company’s common stock as determined pursuant to the Stock Plan on the date of grant (which for the Existing Director Initial Option Grants shall be equal to the price per common equivalent share at which Chess Depositary Interests (“CDIs”) are offered to the public in the contemplated initial public offering of the Company’s CDIs unless otherwise determined by the Compensation Committee prior to the consummation of such offering); and (iii) contain such other terms and conditions as the Board of Directors or the Compensation Committee shall determine prior to the grant of the option. Such options shall become exercisable in full immediately prior to a change of control of the Company. A change of control shall be defined as: (i) any “person” or “group” (as such terms are used in Section 13(d)(3) of the Securities Exchange Act of 1934, as amended, (other than a person or group which is one of our shareholders as of June 16, 2011) is or becomes the beneficial owner, directly or indirectly,

 

2


through a purchase, merger or other acquisition transaction or series of transactions, of our capital stock entitling such person or group to control 50% or more of the total voting power of our capital stock entitled to vote generally in the election of directors, where any voting capital stock of which such person or group is the beneficial owner that are not then outstanding are deemed outstanding for purposes of calculating such percentage; except in connection with our issuance of capital stock in a bona-fide financing transaction the proceeds of which are to be utilized by us for general corporate purposes or (ii) any sale or transfer of all or substantially all of our assets to another person.

Cash Fees

Annual Cash Payments

The following annual cash fees shall be paid to the Outside Directors serving on the Board of Directors and the Audit Committee, Compensation Committee and Nominating and Governance Committee, as applicable. For clarity, an Outside Director is paid for each role that such Outside Director is appointed to although a Chair of a Committee cannot also me considered as a member for compensation purposes.

 

Board of Directors or

Committee of Board of

Directors

   Annual Retainer Amount for
Chair
     Annual Retainer Amount
for Member
 

Board of Directors

   $ 75,000       $ 50,000   

Audit Committee

   $ 15,000       $ 3,000   

Compensation Committee

   $ 10,000       $ 2,000   

Nominating and Governance Committee

   $ 5,000       $ 1,000   

Payment Terms for All Cash Fees

Cash payments payable to Outside Directors shall be paid quarterly in arrears as of the last day of each fiscal quarter commencing as of the Effective Date.

Following an Outside Director’s first election or appointment to the Board of Directors, such Outside Director shall receive his or her cash compensation pro rated beginning on the date he or she was initially appointed or elected. If an Outside Director dies, resigns or is removed during any quarter, he or she shall be entitled to a cash payment on a pro rated basis through his or her last day of service.

 

3


Expenses

Upon presentation of documentation of such expenses reasonably satisfactory to the Company, each Outside Director shall be reimbursed for his or her reasonable out-of-pocket business expenses incurred in connection with attending meetings of the Board of Directors and Committees thereof or in connection with other business related to the Board of Directors.

Amendments

The Compensation Committee or the Board of Directors shall review this Policy from time to time to assess whether any amendments in the type and amount of compensation provided herein should be adjusted in order to fulfill the objectives of this Policy.

 

4

Exhibit 99.1

 

LOGO

GI Dynamics, Inc. – ASX Announcement

GI Dynamics, Inc. Appoints Daniel J. Moore to the Company’s Board of Directors

LEXINGTON, Massachusetts & SYDNEY, Australia – 11 September 2014  –  GI Dynamics, Inc . (ASX: GID) today announced the appointment of Daniel J. Moore, president and CEO of Cyberonics, to the company’s Board of Directors, effective 10 September 2014. Mr. Moore’s appointment expands the Board to seven directors, six of whom are independent directors.

“Dan is an outstanding industry leader with a diverse skill set, extensive international commercial accomplishments, and a strong track record of growing revenues and increasing profitability,” said Jack Meyer, Chairman of the Board of Directors for GI Dynamics. “With his experience leading Cyberonics and commercializing an FDA-approved medical device for epilepsy and depression, conditions that are typically treated with drugs, Dan is a welcome addition to our Board. We are looking forward to the valuable perspective and insights he will provide, especially as we advance our pivotal trial for EndoBarrier in the U.S.”

Mr. Moore has served as president, chief executive office and director of Cyberonics, a medical technology company with core expertise in neuromodulation, since 2007. Under his leadership, Cyberonics has experienced seven consecutive years of improved operating profit and more than doubled its market capitalization to approximately $1.5 billion. Prior to joining Cyberonics, Mr. Moore spent more than 17 years at Boston Scientific where he held positions of increasing responsibility including positions in sales, marketing and senior management in the U.S. and in Europe. Mr. Moore served as president of Inter-Continental, the fourth largest business unit of Boston Scientific with more than 1,000 global employees and revenues exceeding $700 million. In addition to his role on the board at Cyberonics, he serves on the boards of BrainScope Company, Inc., TriVascularTechnologies, Inc., Topera, Inc., BioHouston, the Epilepsy Foundation of Texas, the Epilepsy Foundation of America, and the Medical Device Manufacturers Association (MDMA) where he is the immediate past-chairman. He also serves on the advisory board at the Weldon School of Biomedical Engineering at Purdue University. Mr. Moore holds a B.A. from Harvard University and earned an MBA from Boston University.

“I am pleased to join the GI Dynamics Board as the company strives to mature from a launch stage company to a revenue generating, global commercial organization,” said Mr. Moore. “With the opportunities and challenges related to driving sales while building the case for reimbursement, and the advancement of the U.S. pivotal clinical trial, this is a critical time for the company. I look forward to collaborating with the GI Dynamics Board and management team to further broaden the impact of EndoBarrier on the epidemics of type 2 diabetes and obesity.”

 

www.gidynamics.com   
US OFFICE & HEADQUARTERS:    25 Hartwell Avenue, Lexington MA 02421 T +1 (781) 357-3300 F +1 (781) 357-3301
EUROPEAN OFFICE:    De Tweeling 20-22 ’s-Hertogenbosch 5215 MC, THE NETHERLANDS T: + 31 13 547 9300
AUSTRALIAN OFFICE:    Level 8, 17-19 Bridge Street, Sydney, NSW 2000 T +61 2 9325 9046
GI Dynamics, Inc., is a corporation incorporated in Delaware, USA, whose stockholders have limited liability. ARBN 151 239 388


LOGO

 

GI Dynamics, Inc. - ASX Announcement    Page  2

 

About GI Dynamics

GI Dynamics, Inc. (ASX: GID) is the developer of EndoBarrier ® , the first endoscopically-delivered device therapy approved for the treatment of type 2 diabetes and/or obesity. EndoBarrier is approved and commercially available in multiple countries outside the U.S. EndoBarrier is not approved for sale in the U.S. and is limited by federal law to investigational use only in the United States. GI Dynamics is conducting a pivotal clinical trial of EndoBarrier in the U.S. for the treatment of patients who have uncontrolled type 2 diabetes and are obese. Founded in 2003, GI Dynamics is headquartered in Lexington, Massachusetts. For more information, please visit  www.gidynamics.com .

Forward-Looking Statements

This announcement contains forward-looking statements concerning: our development and commercialization plans; our potential revenues, costs, profitability and financial performance; our ability to obtain reimbursement for our products; our clinical trials, and associated regulatory submissions and approvals; the number and location of commercial centres offering the EndoBarrier ® ; and our intellectual property position. These forward-looking statements are based on the current estimates and expectations of future events by the management of GI Dynamics, Inc. as of the date of this announcement and are subject to a number of risks and uncertainties that could cause actual results to differ materially and adversely from those indicated in or implied by such forward-looking statements, including those described in in our filings with the U.S. Securities and Exchange Commission.

These risks and uncertainties include, but are not limited to: risks associated with the possibility that clinical trials will not be successful or confirm earlier results; risks associated with obtaining funding from third parties; risks relating to the timing and costs of clinical trials, results of clinical trials, the timing of regulatory submissions, the timing and receipt of regulatory approvals, the timing and amount of other expenses; execution risks; competition; risks related to market acceptance of products; intellectual property risks; and assumptions regarding the size of the available market, benefits of our products, product pricing, timing of product launches, future financial results and other factors. Given these uncertainties, you should not place undue reliance on these forward-looking statements. We do not assume any obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, unless required by law.

 

Investor Enquiries:    Media Enquiries:

United States:

Robert Crane, Chief Financial Officer

+1 (781) 357-3250

  

United States/Europe:

Dan Budwick, Pure Communications Inc.

+1 (973) 271-6085

Australia:

David Allen or John Granger,

Hawkesbury Partners Pty Limited

+61 2 9325 9046

  

Australia:

Angela Ceberano, Flourish PR

+61 3 9092 8445

 

www.gidynamics.com   
US OFFICE & HEADQUARTERS:    25 Hartwell Avenue, Lexington MA 02421 T +1 (781) 357-3300 F +1 (781) 357-3301
EUROPEAN OFFICE:    De Tweeling 20-22 ’s-Hertogenbosch 5215 MC, THE NETHERLANDS T: + 31 13 547 9300
AUSTRALIAN OFFICE:    Level 8, 17-19 Bridge Street, Sydney, NSW 2000 T +61 2 9325 9046
GI Dynamics, Inc., is a corporation incorporated in Delaware, USA, whose stockholders have limited liability. ARBN 151 239 388